Provision of Bordetella-Free Baboons for Pertussis Infection and Vaccination Studies
| Bidders ID: | NBD00159188078925330 |
|---|---|
| Due Date: | May 29, 2026 |
| Posted Date: | May 21, 2026 |
| Level of Government: | Federal |
| State: | Maryland |
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Category: |
|
| Solicitation Number: | CBER-2026-134085 |
| Source: | Members Only |
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Sources Sought (Original)
- Original Published Date: May 21, 2026 07:20 am CDT
- Original Response Date: May 29, 2026 01:00 pm CDT
- Inactive Policy: 15 days after response date
- Original Inactive Date: Jun 13, 2026
-
Initiative:
- None
- Original Set Aside: No Set aside used
- Product Service Code: 8820 - LIVE ANIMALS, NOT RAISED FOR FOOD
-
NAICS Code:
- 112990 - All Other Animal Production
-
Place of Performance:
Silver Spring , MD 20993USA
Pertussis is an acute, highly contagious, potentially life-threatening respiratory disease, caused by the Gram-negative bacterium Bordetella pertussis. The underlying factors leading to the failure of public health measures to control pertussis disease using currently licensed vaccines are poorly understood. A more complete understanding of this disease and of the mechanisms of vaccine-mediated protection is a critical public health need.
The baboon model of pertussis, developed in the laboratories of the Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), is the only animal model of pertussis that recapitulates the disease as observed in human patients. Refinement of the baboon model to include establishment of infection by means of natural transmission will enable a more refine evaluation of the differences between the licensed acellular pertussis vaccines that fail to prevent infection and the whole cell vaccines that reduce infection. The performance of this study requires the purchase and delivery of twenty, Bordetella-free baboons.
- 5630 FISHERS LANE HFA-500
- ROCKVILLE , MD 20857
- USA
- David Kramer
- david.kramer@fda.hhs.gov
- Nick Sartain
- nick.sartain@fda.hhs.gov
- May 21, 2026 07:20 am CDTSources Sought (Original)
TRY FOR FREE
Not a GovernmentBidders Member Yet?
Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.
